Regeneron expansion massive vote of confidence for Limerick city region

  • New Limerick Mayor27 810x456
Pictured: Mayor Stephen Keary. Image: Liam Burke

Mayor welcomes additional 300 jobs and US$100 million in Raheen facility.

The Mayor of the City and County of Limerick Cllr Stephen Keary has welcomed the announcement that US biotechnology company Regeneron is to create an additional 300 jobs in Limerick.

Mayor Keary said: “This is fantastic news for Regeneron and for Limerick, with an additional 300 new high-quality jobs being created by the company in Raheen. I'm particularly proud that Dan Van Plew, Regeneron’s executive vice president has confidently proclaimed his belief in Limerick, that it is a place where you can build and thrive as a biotech. The US$100 million investment is a massive vote of confidence for the Limerick city region and the entire ecosystem that has been created here to foster innovation and to make Limerick more attractive for foreign direct investment.

“The latest investment by Regeneron brings to US$750 million the investment the company has made in Limerick since 2013, when it first announced it was planning to come to Limerick. And it is testament to the local workforce, that their hard work and dedication is being recognised by the company and Limerick is being rewarded with this latest expansion.”

Dr Pat Daly, Deputy Chief Executive and Director of Economic Development with Limerick City and County Council said: “We are working with IDA Ireland to create an environment in the Limerick city region that is attractive for companies to invest. Limerick City and County Council is delighted that the strong links between IDA Ireland, the local authority, third level institutions and local business is paying off and seen as a strong selling point for Limerick.”

He added: "An additional 300 jobs will bring to 800 the number of people working in Raheen by the end of next year. This is a fantastic boost to the Limerick economy, and for the entire region, as it increases Limerick’s profile and attractiveness as a location for the biotech sector.”

See More